Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Federal Trade Commission
Colorcon
Medtronic
Farmers Insurance

Generated: July 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Medicis Pharmaceutical Corporation v. Alkem Laboratories Ltd. (D. Del. 2012)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Medicis Pharmaceutical Corporation v. Alkem Laboratories Ltd. (D. Del. 2012)

Docket ➤ Try a Free Trial Date Filed 2012-12-05
Court District Court, D. Delaware Date Terminated 2013-11-14
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Defendant Referred To
Parties ALKEM LABORATORIES LTD.; ASCEND LABORATORIES LLC; MEDICIS PHARMACEUTICAL CORPORATION; PHARMA NETWORK LLC; VALEANT PHARMACEUTICALS INTL., INC.
Patents 5,908,838; 7,790,705; 8,268,804
Attorneys Jack B. Blumenfeld; John C. Phillips , Jr.; Karen Jacobs; Megan C. Haney
Link to Docket External link to docket
Small Molecule Drugs cited in Medicis Pharmaceutical Corporation v. Alkem Laboratories Ltd.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Medicis Pharmaceutical Corporation v. Alkem Laboratories Ltd. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-12-05 1 21, 23, 25, and 27-34 of Medicis’s U.S. Patent No. 5,908,838 as set forth in the duly issued Ex Parte… (“the ’838 patent”), and/or infringement of one or more claims of Medicis’s U.S. Patent No. 7,790,705…“the ’705 patent”), and/or infringement of and one or more claims of Medicis’s U.S. Patent No. 8,268,…in the ’838 patent, entitled “Method for the Treatment of Acne.” The United States Patent and Trademark… covered by the ’838 patent, and Medicis has the right to enforce the ’838 patent. 26. External link to document
2013-11-14 23 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,908,838; 7,790,705; 8,268,804… 14 November 2013 1:12-cv-01663 830 Patent Defendant District Court, D. External link to document
2012-12-05 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,908,838; 7,790,705; 8,268,804… 14 November 2013 1:12-cv-01663 830 Patent Defendant District Court, D. External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Harvard Business School
McKinsey
Deloitte
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.